6/17/2013 8:58:27 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DANBURY, Conn., June 17, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) will present data from human and animal studies with its ultra-rapid-acting prandial insulin product candidates during the 73rd Scientific Sessions of the American Diabetes Association being held at the McCormick Place Convention Center in Chicago, Illinois from June 21 to June 25. The data to be presented demonstrate significant progress in the development of both recombinant human insulin-based and insulin analog-based formulations with ultra-rapid-acting profiles. The presentations are:
Help employers find you! Check out all the jobs and post your resume.
comments powered by